AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
108 hedge funds and large institutions have $417M invested in Aerie Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 53 increasing their positions, 23 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 40
40% less capital invested
Capital invested by funds: $693M → $417M (-$276M)
Holders
108
Holding in Top 10
2
Calls
$5.52M
Puts
$3.77M
Top Buyers
1 | +$28.5M | |
2 | +$28.3M | |
3 | +$12.5M | |
4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$12.2M |
5 |
FCMI
Foresite Capital Management II
Larkspur,
California
|
+$10.5M |
Top Sellers
1 | -$30.3M | |
2 | -$11.2M | |
3 | -$11.1M | |
4 |
HM
HealthCor Management
New York
|
-$11M |
5 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$10.6M |